Asia-Pacific Americas Africa Europe Middle East

IND SWIFT LABORATORIES LIMILED

Company Profile:

IND SWIFT LABORATORIES LIMITED

Company Introduction:

IND SWIFT LABORATORIES LIMITED is a prominent Indian pharmaceutical company primarily engaged in the manufacturing of Active Pharmaceutical Ingredients (APIs) and pharmaceutical intermediates. The company is recognized for its strong research and development capabilities and its commitment to quality and compliance with global regulatory standards. It serves both domestic and international markets, supplying critical raw materials to various pharmaceutical formulations.

Nature of Business:

Factory (Manufacturer)

Enterprise Products

IND SWIFT LABORATORIES LIMITED manufactures and sells a range of Active Pharmaceutical Ingredients (APIs) across various therapeutic categories.

Their product portfolio includes:

Antibiotics

Cephalosporins, Macrolides

Cardiovascular Drugs

Antihypertensives, Lipid-lowering agents

Antidiabetic Drugs

Anti-inflammatory Drugs

Antifungal Drugs

Antidepressants

Antihistamines

Specific APIs often produced include:

Cefuroxime Axetil

Cefixime

Cefpodoxime Proxetil

Clarithromycin

Azithromycin

Roxithromycin

Telmisartan

Rosuvastatin

Atorvastatin

Fexofenadine

Montelukast

Fluconazole

Itraconazole

Voriconazole

Escitalopram Oxalate

Pregabalin

Gabapentin

Business Registration Information:

Manager:

Mr. Gopal Munjal (Chairman & Managing Director)

Phone:

+91-172-5038100, +91-172-2703770

E-mail:

info@indswiftlabs.com

Official Website:
Address:

S.C.O. 136-137, Sector 17-C, Chandigarh - 160017, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.